Skip to content
MedsAcross

Medicine

Ethinyl estradiol and Etonogestrel 0.015 mg/0.12 mg per day extended-release vaginal insert

Available on requestPrescription onlyUS FDA Cold chainGeneric name

Ethinyl estradiol and Etonogestrel 0.015 mg/0.12 mg per day extended-release vaginal insert is a generic prescription medicine for vaginal use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Prior to dispensing to the user, store refrigerated 2° to 8°C (36° to 46°F)…

Key facts

Active ingredient (INN)
Ethinyl estradiol and Etonogestrel
Brand
Sold under the generic name
Strength
0.015 mg/0.12 mg per day
Dosage form
Extended-release vaginal insert
Route
Vaginal
Packs
3 pouches, 1 pouch
Manufacturers
A-S Medication SolutionsPrasco LaboratoriesTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Prior to dispensing to the user, store refrigerated 2° to 8°C (36° to 46°F). After dispensing to the user, etonogestrel and ethinyl estradiol vaginal ring can be stored for up to 4 months at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Avoid storing etonogestrel and ethinyl estradiol vaginal ring in direct sunlight or at temperatures above 30°C (86°F).
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
19 January 2021
Identifiers
RxCUI 1367436DailyMed set ID fcf9da2a-bb91-4697-bfaa-c9d58855e275, a8cc104a-d522-49ad-af54-2f312b829b61, f0d80e01-f4f5-4b1a-bc9e-50a2bd4390b1NDC 50090-5959, 0093-7679, 66993-605Application NDA021187, ANDA204305

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
3 pouch in 1 carton / 21 d in 1 pouch0093-7679-02Teva Pharmaceuticals19 January 2021
1 pouch in 1 box / 1 d in 1 pouch50090-5959-0A-S Medication Solutions7 April 2022
3 pouch in 1 box / 21 d in 1 pouch66993-605-36Prasco Laboratories1 June 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 3 October 2001Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ethinyl estradiol and Etonogestrel 0.015 mg/0.12 mg per day extended-release vaginal insert.

Compare 1

Other strengths and forms of Ethinyl estradiol and Etonogestrel

Clinical summary

Ethinyl estradiol and Etonogestrel is a fixed-dose combination of an estrogen and a progestin indicated by females of reproductive age to prevent pregnancy. It is available as extended-release vaginal inserts and vaginal rings. MedsAcross supplies Ethinyl estradiol and Etonogestrel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ethinyl estradiol and Etonogestrel

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ethinyl estradiol and Etonogestrel 0.015 mg/0.12 mg per day extended-release vaginal insert for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.